CN105153082A - Large-scale production technology of andrographalide - Google Patents
Large-scale production technology of andrographalide Download PDFInfo
- Publication number
- CN105153082A CN105153082A CN201510640417.9A CN201510640417A CN105153082A CN 105153082 A CN105153082 A CN 105153082A CN 201510640417 A CN201510640417 A CN 201510640417A CN 105153082 A CN105153082 A CN 105153082A
- Authority
- CN
- China
- Prior art keywords
- andrographolide
- rographolide
- ethanol
- add
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000011031 large-scale manufacturing process Methods 0.000 title abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 172
- 238000000605 extraction Methods 0.000 claims abstract description 60
- 238000000034 method Methods 0.000 claims abstract description 52
- 238000010992 reflux Methods 0.000 claims abstract description 31
- 239000000463 material Substances 0.000 claims abstract description 26
- 239000002904 solvent Substances 0.000 claims abstract description 20
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 238000011084 recovery Methods 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 46
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 43
- 239000000243 solution Substances 0.000 claims description 36
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 32
- 239000000706 filtrate Substances 0.000 claims description 29
- 238000001556 precipitation Methods 0.000 claims description 26
- 229960001701 chloroform Drugs 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000002425 crystallisation Methods 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 15
- 230000008025 crystallization Effects 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 11
- 102000011759 adducin Human genes 0.000 claims description 9
- 108010076723 adducin Proteins 0.000 claims description 9
- 230000006837 decompression Effects 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 239000012452 mother liquor Substances 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 10
- 238000004064 recycling Methods 0.000 claims 3
- 241000746375 Andrographis Species 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 abstract description 117
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 abstract description 115
- 239000000284 extract Substances 0.000 abstract description 17
- 238000009776 industrial production Methods 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 2
- 244000118350 Andrographis paniculata Species 0.000 description 40
- 238000011835 investigation Methods 0.000 description 25
- 239000002244 precipitate Substances 0.000 description 25
- 238000004042 decolorization Methods 0.000 description 20
- 238000012360 testing method Methods 0.000 description 18
- YIIRVUDGRKEWBV-FZOOCBFYSA-N (3e)-3-[2-[(1r,4as,5r,6r,8as)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1h-naphthalen-1-yl]ethylidene]furan-2-one Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/C=COC1=O YIIRVUDGRKEWBV-FZOOCBFYSA-N 0.000 description 17
- XMJAJFVLHDIEHF-UHFFFAOYSA-N 14-deoxy-11, 12-didehydroandrographolide Natural products OCC1(C)C(O)CCC2(C)C1CCC(=C)C2C=CC1=CCOC1=O XMJAJFVLHDIEHF-UHFFFAOYSA-N 0.000 description 17
- XMJAJFVLHDIEHF-YSDSKTICSA-N dehydroandrographolide Natural products C([C@@H]1C(=C)CC[C@H]2[C@@]1(C)CC[C@@H](O)[C@]2(CO)C)=CC1=CCOC1=O XMJAJFVLHDIEHF-YSDSKTICSA-N 0.000 description 17
- 239000013078 crystal Substances 0.000 description 16
- 229940079593 drug Drugs 0.000 description 15
- 239000003814 drug Substances 0.000 description 14
- 239000013558 reference substance Substances 0.000 description 14
- 238000004128 high performance liquid chromatography Methods 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- 239000012535 impurity Substances 0.000 description 6
- 238000002137 ultrasound extraction Methods 0.000 description 6
- 238000005325 percolation Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000000874 microwave-assisted extraction Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- OXJSCVYFDUXHSF-UHFFFAOYSA-N 3,5-dinitrobenzoic acid ethanol Chemical compound C(C)O.[N+](=O)([O-])C=1C=C(C(=O)O)C=C(C1)[N+](=O)[O-] OXJSCVYFDUXHSF-UHFFFAOYSA-N 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- 241000143437 Aciculosporium take Species 0.000 description 1
- 206010004054 Bacterial upper respiratory tract infections Diseases 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 206010047482 Viral upper respiratory tract infection Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- HYGYSIDIKIGPJA-UHFFFAOYSA-N chloroform;ethyl acetate;methanol Chemical compound OC.ClC(Cl)Cl.CCOC(C)=O HYGYSIDIKIGPJA-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- -1 diterpene lactone compound Chemical class 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000013386 optimize process Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- YLLIGHVCTUPGEH-UHFFFAOYSA-M potassium;ethanol;hydroxide Chemical compound [OH-].[K+].CCO YLLIGHVCTUPGEH-UHFFFAOYSA-M 0.000 description 1
- 238000011028 process validation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000011003 system suitability test Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种穿心莲内酯的大生产工艺。本发明采用适宜工业大规模生产的回流法提取穿心莲内酯,提取效率可达80%以上,可节约大量原药材,节约成本;提取时间仅为2小时每次,提取时间短,避免长时间加热破坏穿心莲内酯;4倍量95%乙醇提取,提取溶剂用量小,且提取溶剂经回收后,可重复利用,大量节约成本。
The invention provides a large-scale production process of andrographolide. The invention adopts the reflux method suitable for large-scale industrial production to extract andrographolide, and the extraction efficiency can reach more than 80%, which can save a large amount of raw medicinal materials and save costs; the extraction time is only 2 hours each time, the extraction time is short, and long-term heating is avoided Destroy andrographolide; extract with 4 times the amount of 95% ethanol, the amount of extraction solvent is small, and the extraction solvent can be reused after recovery, which saves a lot of cost.
Description
技术领域technical field
本发明涉及穿心莲内酯的大生产工艺。The invention relates to a large-scale production process of andrographolide.
背景技术Background technique
穿心莲内酯,分子式C20H30O5,天然植物穿心莲的主要有效成份,具有祛热解毒,消炎止痛之功效,对细菌性与病毒性上呼吸道感染及痢疾有特殊疗效,被誉为天然抗生素药物。本品为二萜类内酯化合物,均难溶于水,通常仅能口服给药。Andrographolide, molecular formula C20H30O5, is the main active ingredient of the natural plant Andrographis paniculata. It has the effects of dispelling heat and detoxification, reducing inflammation and relieving pain, and has special effects on bacterial and viral upper respiratory tract infections and dysentery. It is known as a natural antibiotic drug. This product is a diterpene lactone compound, which is insoluble in water and can only be administered orally.
目前公开的穿心莲内酯的制备方法有:专利申请号200710142800.7,公开了一种醇提后用树脂分离的方法。大孔树脂法洗脱时不同浓度乙醇洗脱物均不同程度含有穿心莲内酯,80%乙醇洗脱物含量较高,但收率较低。鹿萍等的文献(穿心莲内酯的超声波提取法研究,赤峰学院学报(自然科学版)第24卷第2期,2008)报道了以穿心莲茎杆粉末为原料,采用超声波辅助提取穿心莲内酯。结果表明最理想的提取溶剂为75%乙醇,料也比为1:20,超声时间为40分钟效果最佳。马芝玉等的文献(微波和超声波辅助提取穿心莲内酯,精细化工第24卷第8期,2007)报道了以穿心莲茎叶为原料,分别采用超声辅助提取和微波辅助提取穿心莲内酯。结果超声辅助提取最佳工艺条件为提取溶剂为75%乙醇,超声效率为40%、超声时间为50分钟;微波辅助提取最佳工艺条件为温度为40℃,提取溶剂为75%乙醇,提取时间为8分钟。超声波辅助提取、微波辅助提取法在某些条件下具有积极的效果,但这两种方法难以应用于工业化大生产。The currently disclosed preparation methods of andrographolide include: Patent Application No. 200710142800.7, which discloses a method of separation with resin after alcohol extraction. The eluates with different concentrations of ethanol contained andrographolide to varying degrees when eluted by the macroporous resin method, and the eluate with 80% ethanol had a higher content, but the yield was lower. The literature of Lu Ping et al. (Study on Ultrasonic Extraction of Andrographolide, Journal of Chifeng University (Natural Science Edition) Volume 24, No. 2, 2008) reported that Andrographolide was extracted with ultrasonic-assisted extraction of Andrographolide stem powder. The results show that the most ideal extraction solvent is 75% ethanol, the ratio of material to material is 1:20, and the ultrasonic time is 40 minutes. The literature of Ma Zhiyu et al. (Microwave and Ultrasonic Assisted Extraction of Andrographolide, Fine Chemical Industry Volume 24, No. 8, 2007) reported that the stems and leaves of Andrographis paniculata were used as raw materials, and ultrasonic-assisted extraction and microwave-assisted extraction of andrographolide were used respectively. Results The optimal technological conditions of ultrasonic-assisted extraction were 75% ethanol as the extraction solvent, 40% ultrasonic efficiency, and 50 minutes of ultrasonic time; for 8 minutes. Ultrasonic-assisted extraction and microwave-assisted extraction have positive effects under certain conditions, but these two methods are difficult to apply to large-scale industrial production.
发明内容Contents of the invention
本发明的技术方案提供了穿心莲内酯的大生产工艺。The technical scheme of the invention provides a large-scale production process of andrographolide.
本发明提供了一种穿心莲内酯的大生产工艺,它包括如下步骤:The invention provides a kind of large-scale production technique of andrographolide, and it comprises the steps:
a、取穿心莲粗粉,加入95%乙醇或甲醇浸润,再加入95%乙醇或甲醇,加热回流提取,过滤,合并滤液;a. Take Andrographis paniculata coarse powder, add 95% ethanol or methanol to infiltrate, then add 95% ethanol or methanol, heat and reflux for extraction, filter, and combine the filtrates;
b、滤液加蒸馏水调节乙醇浓度至55%-85%,室温静置,过滤,得滤液;b. Add distilled water to the filtrate to adjust the ethanol concentration to 55%-85%, let it stand at room temperature, and filter to obtain the filtrate;
c、滤液加0.4-0.8%活性炭粉末,加热回流脱色,过滤;c. Add 0.4-0.8% activated carbon powder to the filtrate, heat to reflux for decolorization, and filter;
d、滤液减压回收乙醇至1-10g/ml(药材量/浓缩液体积),4℃静置,过滤,得穿心莲内酯沉淀;d. Recover the ethanol from the filtrate to 1-10g/ml (the amount of medicinal material/the volume of the concentrated solution), let it stand at 4°C, and filter to obtain the precipitation of andrographolide;
e、穿心莲内酯沉淀加少量80%乙醇洗涤,洗涤至类白色,再加少量水洗涤至水溶液无色,得穿心莲内酯白色粉末;e, adding a small amount of 80% ethanol to the andrographolide precipitate, washing until it is off-white, and then washing with a small amount of water until the aqueous solution is colorless, to obtain a white powder of andrographolide;
f、将e步骤制备的穿心莲内酯白色粉末加三氯甲烷静置,过滤,得精制穿心莲内酯粉末;f, the andrographolide white powder prepared by step e is added with chloroform to leave standstill, filter, and obtain refined andrographolide powder;
g、加入95%乙醇,加热使精制穿心莲内酯粉末溶解,过滤,减压回收乙醇至半量,4℃静置过夜,使析晶,过滤,得穿心莲内酯结晶;母液再次减压回收溶剂至半量,过滤,合并穿心莲内酯结晶,减压干燥,即得。g, add 95% ethanol, heat to dissolve the refined andrographolide powder, filter, reclaim the ethanol to half the amount under reduced pressure, let it stand overnight at 4°C, make crystallization, filter, and obtain andrographolide crystallization; Half the amount, filtered, combined andrographolide crystals, dried under reduced pressure, that is.
其中,a步骤所述的提取溶剂为95%乙醇。a步骤所述的提取工艺为:每次加入95%乙醇4倍量,回流提取3次,每次2h。Wherein, the extraction solvent described in step a is 95% ethanol. The extraction process described in step a is: add 4 times the amount of 95% ethanol each time, and reflux extraction for 3 times, each time for 2 hours.
其中,b步骤所述的乙醇浓度至65%。Wherein, the ethanol concentration described in step b is up to 65%.
b步骤所述的静置时间为36小时。The standing time described in step b is 36 hours.
c步骤所述的活性炭的用量为0.5%。The consumption of the gac described in c step is 0.5%.
c步骤所述的活性炭脱色时间0.5-3小时。The activated carbon decolorization time described in step c is 0.5-3 hours.
d步骤所述的滤液减压回收乙醇至1g/ml。The filtrate described in d step reclaims ethanol under reduced pressure to 1g/ml.
f步骤所述的10倍量三氯甲烷静置1小时,静置3次。10 times the amount of chloroform described in step f was left standing for 1 hour, and left standing 3 times.
g步骤所述的减压干燥条件为:50℃减压干燥2小时。The vacuum drying condition described in step g is: drying under reduced pressure at 50° C. for 2 hours.
本发明采用适宜工业大规模生产的回流法提取穿心莲内酯,提取效率可达80%以上,可节约大量原药材,节约成本;提取时间仅为2小时每次,提取时间短,避免长时间加热破坏穿心莲内酯;4倍量95%乙醇提取,提取溶剂用量小,且提取溶剂经回收后,可重复利用,大量节约成本。The invention adopts the reflux method suitable for large-scale industrial production to extract andrographolide, and the extraction efficiency can reach more than 80%, which can save a large amount of raw medicinal materials and save costs; the extraction time is only 2 hours each time, the extraction time is short, and long-term heating is avoided Destroy andrographolide; extract with 4 times the amount of 95% ethanol, the amount of extraction solvent is small, and the extraction solvent can be reused after recovery, which saves a lot of cost.
附图说明Description of drawings
图1工艺流程图Figure 1 process flow chart
图2穿心莲TLC(A-紫外灯下穿心莲TLC;B-日光下穿心莲TLC;S1-穿心莲内酯;S2-脱水穿心莲内酯;1-混合对照品;2-穿心莲对照药材;3-CXL1;4-CXL2;5-CXL3)Figure 2 Andrographis paniculata TLC (A-andrographis paniculata TLC under ultraviolet lamp; B-andrographis paniculata TLC under sunlight; S1-andrographolide; S2-dehydroandrographolide; 1-mixed reference substance; 2-andrographis paniculata reference medicinal material; 3-CXL1; 4 -CXL2; 5-CXL3)
图3254nm条件下空白溶剂HPLC色谱图Figure 3254nm blank solvent HPLC chromatogram
图4225nm条件下空白溶剂HPLC色谱图Figure 4225nm condition blank solvent HPLC chromatogram
图5254nm条件下混合对照品HPLC色谱图(1-穿心莲内酯;2-脱水穿心莲内酯)Mixed reference substance HPLC chromatogram (1-andrographolide; 2-dehydroandrographolide) under the condition of figure 5254nm
图6225nm条件下混合对照品HPLC色谱图(1-穿心莲内酯;2-脱水穿心莲内酯)Mixed reference substance HPLC chromatogram (1-andrographolide; 2-dehydroandrographolide) under the condition of figure 6225nm
图7254nm条件下样品HPLC色谱图(1-穿心莲内酯;2-脱水穿心莲内酯)Sample HPLC chromatogram (1-andrographolide; 2-dehydroandrographolide) under the condition of figure 7254nm
图8225nm条件下样品HPLC色谱图(1-穿心莲内酯;2-脱水穿心莲内酯)Sample HPLC chromatogram (1-andrographolide; 2-dehydroandrographolide) under the condition of Fig. 8225nm
图9脱水穿心莲内酯标准曲线Fig. 9 dehydroandrographolide standard curve
图10穿心莲内酯标准曲线Figure 10 andrographolide standard curve
图11穿心莲浓缩体积考察Fig. 11 Investigation of concentrated volume of Andrographis paniculata
图12穿心莲内酯TLC(1-J1;2-J2;3-J3)Figure 12 TLC of andrographolide (1-J1; 2-J2; 3-J3)
图13穿心莲内酯对照品HPLC色谱图(1-穿心莲内酯)Figure 13 andrographolide reference substance HPLC chromatogram (1-andrographolide)
图14结晶HPLC色谱图(1-穿心莲内酯)Figure 14 Crystalline HPLC chromatogram (1-andrographolide)
具体实施方式Detailed ways
实施例1本发明穿心莲内酯的提取工艺(工艺流程图见图1)The extraction process of embodiment 1 andrographolide of the present invention (process flow chart sees Fig. 1)
1实验仪器与材料1 Experimental instruments and materials
1.1实验仪器1.1 Experimental Instruments
ShimadzuLC-20AT高效液相色谱仪(日本岛津公司),SIL-20A自动进样器,SPD-20A检测器,CTO-20A柱温箱,LCsolution色谱工作站软件,BP211D电子分析天平(德国Sartouris股份有限公司),旋转蒸发仪RE-2000B(上海亚荣生化仪器厂);UPT-I-10T优普系列超纯水机(成都超纯科技有限公司);BP211D型电子分析天平(十万分之一)(德国Sartorius公司)、BP121S型(万分之一)(德国Sartorius公司)、SB25-12D型超声波清洗器(宁波新艺超声设备有限公司);电热鼓风干燥箱(型号:DB-211SD)。Shimadzu LC-20AT high performance liquid chromatography (Shimadzu, Japan), SIL-20A autosampler, SPD-20A detector, CTO-20A column thermostat, LCsolution chromatographic workstation software, BP211D electronic analytical balance (Germany Sartouris Co., Ltd. company), rotary evaporator RE-2000B (Shanghai Yarong Biochemical Instrument Factory); UPT-I-10T Youpu series ultrapure water machine (Chengdu Ultrapure Technology Co., Ltd.); BP211D electronic analytical balance (1/100,000 ) (German Sartorius Company), BP121S (1/10,000) (German Sartorius Company), SB25-12D Ultrasonic Cleaner (Ningbo Xinyi Ultrasonic Equipment Co., Ltd.); Electric Blast Drying Oven (Model: DB-211SD) .
1.2实验材料1.2 Experimental materials
1.2.1药材1.2.1 Medicinal materials
共收集穿心莲药材3批,其中1批购自成都荷花池药材专业市场,产地不详,1批购自成都中医药大学附属医院,产地不详,1批药材购自清远圣芝堂现代中药有限公司,产地为广东清远。药材收集情况见表1。A total of 3 batches of Andrographis paniculata were collected, one batch was purchased from Chengdu Hehuachi medicinal materials professional market, the origin is unknown, the other batch was purchased from the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, the origin is unknown, and the other batch was purchased from Qingyuan Shengzhitang Modern Chinese Medicine Co., Ltd. The place of origin is Qingyuan, Guangdong. See Table 1 for medicinal materials collection.
表1穿心莲药材收集Table 1 Collection of Andrographis paniculata
“-”表示不详清"-" means unclear
1.2.2试药与试剂1.2.2 Reagents and Reagents
穿心莲对照药材(中国食品药品检定院,批号121082-200603),穿心莲内酯(中国食品药品检定院,供含量测定用,110797-201108),脱水穿心莲内酯(中国食品药品检定院,供含量测定用,批号110854-201308),水为超纯水,甲醇为色谱纯(国药集团化学试剂有限公司),其他试剂均为分析纯。Andrographis paniculata reference medicinal material (China Food and Drug Control Institute, batch number 121082-200603), andrographolide (China Food and Drug Control Institute, for content determination, 110797-201108), dehydroandrographolide (China Food and Drug Control Institute, for content determination (batch number 110854-201308), water was ultrapure water, methanol was chromatographically pure (Sinopharm Chemical Reagent Co., Ltd.), and other reagents were analytically pure.
2穿心莲药材质量检查2 Quality inspection of Andrographis paniculata
21薄层色谱鉴别21 TLC identification
2.1.1供试品溶液的制备2.1.1 Preparation of the test solution
取本品粉末(过四号筛)约0.5g,精密称定,置具塞锥形瓶中,精密加入40%甲醇25ml,称定重量,浸泡1小时,超声处理(功率250W,频率33kHz)30分钟,放冷,再称定重量,用40%甲醇补足减失的重量,摇匀,滤过。精密量取续滤液10ml,置中性氧化铝柱(200~300目,5g,内径为1.5cm)上,用甲醇15ml洗脱,收集洗脱液,置50ml量瓶中,加甲醇至刻度,摇匀,即得。Take about 0.5g of the powder of this product (passed through a No. 4 sieve), accurately weigh it, put it in a stoppered Erlenmeyer flask, add 25ml of 40% methanol accurately, weigh it, soak for 1 hour, and perform ultrasonic treatment (power 250W, frequency 33kHz) After 30 minutes, let it cool down, weigh it again, make up the lost weight with 40% methanol, shake well, and filter. Precisely measure 10ml of the continued filtrate, put it on a neutral alumina column (200-300 mesh, 5g, inner diameter of 1.5cm), elute with 15ml of methanol, collect the eluate, put it in a 50ml measuring bottle, add methanol to the mark, Shake well and serve.
2.1.2对照药材溶液的制备2.1.2 Preparation of reference medicinal solution
取穿心莲对照药材0.5g,加乙醇30ml,超声处理30分钟,滤过,滤液浓缩至5ml,作为对照药材溶液。Take Andrographis paniculata reference drug 0.5g, add ethanol 30ml, ultrasonic treatment for 30 minutes, filter, and the filtrate is concentrated to 5ml, as the reference drug solution.
2.1.3对照品溶液的制备2.1.3 Preparation of reference solution
再取脱水穿心莲内酯对照品、穿心莲内酯对照品,加无水乙醇制成每1ml各含1mg的混合溶液,作为对照品溶液。Then take the dehydrated andrographolide reference substance and the andrographolide reference substance, add absolute ethanol to make a mixed solution each containing 1mg per 1ml, as the reference substance solution.
照薄层色谱法(附录VIB)试验,吸取上述供试品溶液、对照药材溶液各6μl和对照品溶液4μl,分别点于同一硅胶GF254薄层板上,以三氯甲烷-乙酸乙酯-甲醇(4:3:0.4)为展开剂,展开,取出,晾干,置紫外光灯(254nm)下检视。供试品色谱中,在与对照药材色谱和对照品色谱相应的位置上,分别显相同颜色的斑点;喷以2%3,5-二硝基苯甲酸乙醇溶液-2mol/L氢氧化钾溶液(1:1)混合溶液(临用配制),立即在日光下检视。供试品色谱中,在与对照药材色谱和对照品色谱相应的位置上,分别显相同颜色的斑点。(见图2)According to the thin-layer chromatography (Appendix VIB) test, draw the above-mentioned need testing solution, 6 μl of the reference medicinal material solution and 4 μl of the reference solution, respectively spot on the same silica gel GF 254 thin-layer plate, and use chloroform-ethyl acetate- Methanol (4:3:0.4) was used as the developer, developed, taken out, dried in the air, and inspected under ultraviolet light (254nm). In the chromatogram of the test product, on the positions corresponding to the chromatogram of the contrast medicinal material and the chromatogram of the reference substance, spots of the same color are shown respectively; spray with 2% 3,5-dinitrobenzoic acid ethanol solution-2mol/L potassium hydroxide solution (1:1) mixed solution (pre-use preparation), immediately inspected under sunlight. In the chromatogram of the test product, spots of the same color are displayed at the positions corresponding to the chromatogram of the reference medicinal material and the chromatogram of the reference product. (See Figure 2)
2.2水分测定2.2 Moisture determination
照《中国药典》2010年一部(附录ⅨH第一法),测定。结果见表2。Measure according to "Chinese Pharmacopoeia" in 2010 (Appendix IX H first method). The results are shown in Table 2.
表2.穿心莲药材水分测定(n=3)Table 2. Moisture determination of Andrographis paniculata (n=3)
2.3含量测定2.3 Content determination
照《中国药典》2010年版一部高效液相色谱法(附录ⅥD)测定,色谱条件、对照品溶液制备、供试品溶液制备同《中国药典》2010年版一部穿心莲含量测定项下。对照品及样品HPLC色谱图见图3~8。Measure according to "Chinese Pharmacopoeia" 2010 edition one high performance liquid chromatography (appendix VI D), chromatographic conditions, reference substance solution preparation, need testing solution preparation are with " Chinese pharmacopoeia " 2010 edition one one Andrographis paniculata content determination item. The HPLC chromatograms of reference substances and samples are shown in Figures 3-8.
2.3.1标准曲线2.3.1 Standard curve
分别取上述混合对照品溶液2μl、5μl、10μl、15μl、20μl注入液相色谱仪,按“2.4.1“项下方法测定峰面积,并以峰面积为纵坐标,进样量为横坐标,绘制标准曲线,回归方程见表3,图9-10。Take 2 μl, 5 μl, 10 μl, 15 μl, and 20 μl of the above-mentioned mixed reference substance solution and inject them into the liquid chromatograph, measure the peak area according to the method under "2.4.1", and take the peak area as the ordinate, and the injection volume as the abscissa, Draw a standard curve, the regression equation is shown in Table 3, Figure 9-10.
表3.标准曲线Table 3. Standard curve
由表3可知,脱水穿心莲内酯在0.1848~1.848μg范围内呈良好的线性关系,穿心莲内酯在0.1964~1.946μg范围内呈良好的线性关系。It can be known from Table 3 that the dehydroandrographolide has a good linear relationship in the range of 0.1848-1.848 μg, and the andrographolide has a good linear relationship in the range of 0.1964-1.946 μg.
2.3.2测定结果2.3.2 Measurement results
穿心莲药材HPLC含量测定结果见表4。See Table 4 for the results of HPLC determination of Andrographis paniculata medicinal material.
表4.穿心莲含量测定(n=3)Table 4. Andrographis paniculata content determination (n=3)
HPLC含量测定结果表明脱水穿心莲内酯理论塔板数为6084,穿心莲内酯理论塔板数为4305,符合《中国药典》2010年版一部穿心莲含量测定项下规定。The HPLC content determination results show that the theoretical plate number of dehydroandrographolide is 6084, and the theoretical plate number of andrographolide is 4305, which is in line with the regulations under the content determination item of Andrographis paniculata in the 2010 edition of "Chinese Pharmacopoeia".
由表4可知CXL1样品穿心莲内酯与脱水穿心莲内酯含量不合格,CXL2、CXL3样品穿心莲内酯与脱水穿心莲内酯含量均符合《中国药典》2010年版一部穿心莲含量测定项下规定,但由于CXL2产地并不明确,不符合《关于征求加强中药提取和提取物监督管理意见的函》相关规定,且其穿心莲内酯含量低于产地明确的CXL3样品含量,故选择CXL3样品进行试验研究。As can be seen from Table 4, the content of andrographolide and dehydroandrographolide in CXL1 samples is unqualified, and the contents of andrographolide and dehydroandrographolide in samples CXL2 and CXL3 all meet the regulations under the determination item of Andrographis paniculata in the 2010 edition of the Chinese Pharmacopoeia, but due to The origin of CXL2 is not clear, and it does not comply with the relevant provisions of the "Letter on Soliciting Opinions on Strengthening the Supervision and Management of Chinese Medicine Extraction and Extracts", and its andrographolide content is lower than that of the CXL3 sample with a clear origin, so the CXL3 sample was selected for experimental research.
3穿心莲内酯制备3 andrographolide preparation
实验对穿心莲内酯提取、纯化等关键性工艺进行了系统研究。结果如下。In the experiment, the key processes such as extraction and purification of andrographolide were systematically studied. The result is as follows.
3.1穿心莲药材前处理3.1 Pretreatment of Andrographis paniculata
将穿心莲药材粉碎成粗粉。Crush the Andrographis paniculata into coarse powder.
3.2提取3.2 Extraction
3.1.1提取方法考察3.1.1 Investigation of extraction methods
试验研究对比研究了适宜工业大生产的浸渍法、渗漉法、回流法3种方法对穿心莲内酯提取效率的影响,方法及结果如下。The experimental research compared and studied the effects of three methods, which are suitable for industrial production, immersion method, percolation method and reflux method, on the extraction efficiency of andrographolide. The methods and results are as follows.
浸渍法:取穿心莲药材粗粉3份,每份25g,分别加入1.5倍量95%乙醇浸润30分钟。再加入5倍量95%乙醇55℃水浴温浸2次,每次12小时,过滤,合并滤液。得浸渍提取液。Immersion method: take 3 parts of Andrographis paniculata crude powder, each 25g, add 1.5 times the amount of 95% ethanol to soak for 30 minutes. Then add 5 times the amount of 95% ethanol and soak in a 55°C water bath for 2 times, each time for 12 hours, filter, and combine the filtrates. Get the soaking extract.
渗漉法:取穿心莲药材粗粉3份,每份25g,分别加入1.5倍量95%乙醇浸润30分钟。以1~3ml/min速度缓慢收集渗漉液250ml(边渗漉边加95%乙醇)。得渗漉提取液。Percolation method: take 3 parts of Andrographis paniculata crude powder, each 25g, add 1.5 times the amount of 95% ethanol to infiltrate for 30 minutes. Slowly collect 250ml of percolate at a speed of 1-3ml/min (add 95% ethanol while percolating). Obtain percolation extract.
回流法:取穿心莲药材粗粉3份,每份25g,分别加入1.5倍量95%乙醇浸润30分钟。加入5倍量95%乙醇回流提取2次,每次3小时,过滤,合并滤液。得回流提取液。Reflux method: take 3 parts of Andrographis paniculata crude powder, 25g each, add 1.5 times the amount of 95% ethanol to infiltrate for 30 minutes. Add 5 times the amount of 95% ethanol to reflux for extraction twice, each time for 3 hours, filter, and combine the filtrates. The reflux extract was obtained.
分别取上述浸渍提取液、渗漉提取液、回流提取液1ml置10ml容量瓶中,加95%乙醇定容至刻度,取续滤液,测定各提取液中穿心莲内酯浓度,计算穿心莲内酯提出量。以穿心莲内酯转移率为指标,考察提取方法。结果见表5。Take the above-mentioned soaking extract, percolation extract, and reflux extract 1ml respectively and put them in a 10ml volumetric flask, add 95% ethanol to make the volume up to the mark, take the subsequent filtrate, measure the concentration of andrographolide in each extract, and calculate the concentration of andrographolide. quantity. The transfer rate of andrographolide was used as an index to investigate the extraction method. The results are shown in Table 5.
表5穿心莲内酯提取方法考察Table 5 andrographolide extraction method investigation
由表5可见,采用浸渍法和渗漉法提取效果相似,回流法提取效率最高,采用回流法进行试验。It can be seen from Table 5 that the extraction effects of the dipping method and the percolation method are similar, and the extraction efficiency of the reflux method is the highest, and the reflux method is used for the test.
3.2.2提取溶剂考察3.2.2 Investigation of extraction solvent
取穿心莲药材粗粉2份,每份25g,分别加入1.5倍量95%乙醇和甲醇浸润30分钟。分别加入5倍量95%乙醇和甲醇回流提取2次,每次3小时,过滤,合并滤液,将滤液定容至500ml。得回流提取液。结果见表6。Take 2 portions of Andrographis paniculata crude powder, 25g each, add 1.5 times the amount of 95% ethanol and methanol to infiltrate for 30 minutes. Add 5 times the amount of 95% ethanol and methanol to reflux extraction twice, each time for 3 hours, filter, combine the filtrate, and dilute the filtrate to 500ml. The reflux extract was obtained. The results are shown in Table 6.
表6提取溶剂考察Table 6 Extraction Solvent Investigation
由表6可见,采用95%乙醇和甲醇作为提取溶剂对穿心莲内酯提取率影响无较大差异,考虑到采用甲醇作为提取溶剂成本较高,且甲醇残留在临床使用时有一定的安全隐患,故选择95%乙醇作为提取溶剂。As can be seen from Table 6, the use of 95% ethanol and methanol as the extraction solvent has no significant difference in the extraction rate of andrographolide. Considering that the cost of using methanol as the extraction solvent is high, and methanol residues have certain potential safety hazards in clinical use, Therefore, 95% ethanol was chosen as the extraction solvent.
3.2.3正交设计优化关键工艺参数3.2.3 Orthogonal design to optimize key process parameters
乙醇浓度、乙醇用量、提取时间、提取次数对穿心莲内酯的提取效率有较大影响,故选择上述4个因素分别设置3个水平,考察其对穿心莲内酯提取效率的影响,因素水平设计见表7。The concentration of ethanol, the amount of ethanol, the extraction time, and the number of extractions have a great influence on the extraction efficiency of andrographolide. Therefore, the above four factors are selected to set three levels respectively to investigate their influence on the extraction efficiency of andrographolide. For the design of factor levels, see Table 7.
取穿心莲药材,每份约25g,以95%乙醇作为提取溶剂,按照正交试验表进行试验,合并滤液,滤液按照穿心莲药材含量测定方法测定穿心莲内酯含量。正交设计及结果见表8。Get the Andrographis paniculata medicinal material, each about 25g, use 95% ethanol as the extraction solvent, test according to the orthogonal test table, combine the filtrate, and the filtrate measures the andrographolide content according to the Andrographis paniculata medicinal material content determination method. Orthogonal design and results are shown in Table 8.
表7试验因素水平表Table 7 Test factor level table
表8正交实验结果(n=2)Table 8 Orthogonal Experimental Results (n=2)
对正交试验结果进行方差分析,由于A因素SS值小于误差,故归于误差后再次进行分析,结果见表9。The variance analysis was carried out on the results of the orthogonal test. Since the SS value of factor A was less than the error, it was attributed to the error and then analyzed again. The results are shown in Table 9.
表9正交试验方差分析结果Table 9 Orthogonal test analysis of variance results
对正交试验进行直观分析和方差分析可知,各因素对穿心莲提取率影响顺序为C>D>B>A,即提取次数为主要因素,提取时间为重要因素,乙醇浓度、料液比为次要因素,考虑到低浓度乙醇提出水溶性杂质较多,故乙醇浓度选择95%乙醇。由此得最佳提取工艺D3C2B2A1,即每次加入95%乙醇4倍量,回流提取3次,每次2h。Carrying out visual analysis and analysis of variance to orthogonal experiment, we can know that the influence order of each factor on the extraction rate of Andrographis paniculata is C>D>B>A, that is, the number of extractions is the main factor, the extraction time is the important factor, and the concentration of ethanol and the ratio of solid to liquid are secondary. Important factors, considering that low-concentration ethanol brings out more water-soluble impurities, so the ethanol concentration is selected as 95% ethanol. Thus the optimal extraction process D 3 C 2 B 2 A 1 was obtained, that is, adding 4 times the amount of 95% ethanol each time, and refluxing extraction 3 times, 2 hours each time.
3.2.4提取工艺验证试验3.2.4 Extraction process verification test
取穿心莲药材粉末200g,加入4倍量95%乙醇,回流提取3次,每次2h。结果见表10。Take Andrographis paniculata medicinal powder 200g, add 4 times the amount of 95% ethanol, reflux extraction 3 times, each time 2h. The results are shown in Table 10.
表10提取工艺验证试验Table 10 Extraction process verification test
由表10可见,工艺经优化后穿心莲内酯提取率平均为83.28,RSD为0.80%,表明经优化后的工艺提取率较高,且稳定。It can be seen from Table 10 that the average extraction rate of andrographolide after the process optimization is 83.28, and the RSD is 0.80%, indicating that the extraction rate of the optimized process is high and stable.
3.3纯化工艺考察3.3 Investigation of purification process
穿心莲内酯纯化采用水沉、加活性炭回流的方法除去叶绿素等杂质,采用三氯甲烷静置除去脱水穿心莲内酯,最后采用乙醇重结晶的方法得到穿心莲内酯结晶。The purification of andrographolide adopts the method of water precipitation and reflux with activated carbon to remove impurities such as chlorophyll, uses chloroform to stand still to remove dehydrated andrographolide, and finally adopts the method of ethanol recrystallization to obtain andrographolide crystals.
3.3.1调节乙醇浓度考察3.3.1 Adjustment of ethanol concentration investigation
取3.2.4中穿心莲提取液100ml(相当于生药量9g),加入适量蒸馏水调节乙醇浓度分别为55%、65%、75%、85%,静置过夜后观察沉淀情况及过滤情况,并测定溶液中穿心莲内酯含量,计算穿心莲内酯减失量。结果见表11。Take 100ml of Andrographis paniculata extract in 3.2.4 (equivalent to 9g of crude drug), add appropriate amount of distilled water to adjust the ethanol concentration to 55%, 65%, 75%, and 85% respectively, observe the precipitation and filtration after standing overnight, and determine The content of andrographolide in the solution was used to calculate the loss of andrographolide. The results are shown in Table 11.
表11调节乙醇浓度考察(n=3)Table 11 regulates ethanol concentration investigation (n=3)
“+”表示有沉淀析出,“+++”表示沉淀量最大,“—”表示无沉淀析出"+" means precipitation, "+++" means the largest amount of precipitation, "—" means no precipitation
“**”表示可过滤,“***”表示易过滤"**" means filterable, "***" means easy to filter
由表11可见,加水调节调节乙醇浓度为55%后穿心莲内酯含量有少量降低,65%~95%则无明显变化,且调节乙醇浓度为65%时有大量沉淀析出,且过滤迅速,故选择调节乙醇浓度为65%即可。As can be seen from Table 11, the content of andrographolide has a small decrease after adding water to adjust the ethanol concentration to 55%, but there is no significant change at 65% to 95%, and there is a large amount of precipitation when the ethanol concentration is adjusted to 65%, and the filtration is rapid, so Choose to adjust the ethanol concentration to 65%.
3.3.2水沉静置时间考察3.3.2 Investigation of the standing time of water sinking
取穿心莲药材粉末500g,按3.2.4中提取方法提取的穿心莲内酯提取液并测定提取液中穿心莲内酯含量,加提取液分为3份,分别加入相当于生药6倍量蒸馏水静置,分别于3、6、12、24、36小时取样测定其穿心莲内酯含量,计算穿心莲内酯减失量,并观察沉淀情况。结果见表12。Get Andrographis paniculata medicinal material powder 500g, press the andrographolide extract solution extracted by the extraction method in 3.2.4 and measure the andrographolide content in the extract solution, add the extract solution and be divided into 3 parts, add the distilled water equivalent to 6 times the amount of crude drug respectively and let it stand, Samples were taken at 3, 6, 12, 24, and 36 hours to measure the andrographolide content, and the loss of andrographolide was calculated, and the precipitation was observed. The results are shown in Table 12.
表12加水沉淀时间考察(n=3)Table 12 adds water precipitation time investigation (n=3)
“+”表示有沉淀析出,“+++”表示沉淀量最大,“—”表示无沉淀析出"+" means precipitation, "+++" means the largest amount of precipitation, "—" means no precipitation
“**”表示可过滤,“***”表示易过滤"**" means filterable, "***" means easy to filter
由表12可见,加水后静置36小时,沉淀完全且穿心莲内酯含量无明显变化,即加水后室温静置36小时即可。It can be seen from Table 12 that after adding water and standing still for 36 hours, the precipitation is complete and the content of andrographolide has no obvious change, that is, after adding water, let stand at room temperature for 36 hours.
3.3.3活性炭脱色考察3.3.3 Activated carbon decolorization investigation
3.3.3.1活性炭用量考察3.3.3.1 Investigation on the dosage of activated carbon
取3.3.2中穿心莲提取液3份,每份500ml(相当于生药量30g),加入2.0g、2.5g、3g、3.5g、4.0g活性炭粉末,相当于溶液量0.4%、0.5%、0.6%、0.7%、0.8%,回流脱色1小时,冷却后观察脱色液颜色并测定穿心莲内酯含量,计算穿心莲内酯减失量。结果见表13。Take 3 parts of Andrographis paniculata extract in 3.3.2, each 500ml (equivalent to 30g of crude drug), add 2.0g, 2.5g, 3g, 3.5g, 4.0g of activated carbon powder, equivalent to 0.4%, 0.5%, 0.6% of the solution %, 0.7%, 0.8%, reflux decolorization for 1 hour, observe the color of the decolorization solution after cooling and measure the content of andrographolide, and calculate the loss of andrographolide. The results are shown in Table 13.
表13活性炭加入量考察(n=3)Table 13 Investigation of the amount of activated carbon added (n=3)
“+”表示颜色最浅,““++”表示颜色较浅“+++”表示颜色较深,“++++”表示颜色最深"+" indicates the lightest color, ""++" indicates the lighter color, "+++" indicates the darker color, and "++++" indicates the darkest color
由表13可见,加入溶液量0.4%~0.5%活性炭回流脱色1小时穿心莲内含量无明显降低,且无脱色液中无明显可见绿色,当活性炭加入量大于溶液量0.5%时穿心莲内酯含量明显降低,故活性炭用量取药材量0.5%即可。It can be seen from Table 13 that the content of andrographis paniculata was not significantly reduced by adding 0.4% to 0.5% of the solution to reflux for decolorization for 1 hour, and there was no obvious green color in the decolorization solution. When the amount of activated carbon added was greater than 0.5% of the solution, the content of andrographolide was obvious Reduce, so the active carbon consumption gets final product 0.5% of medicinal material amount.
3.3.3.1脱色时间考察3.3.3.1 Inspection of decolorization time
取3.3.2中穿心莲提取液4份,每份500ml(相当于生药量30g),加入2.5g活性炭粉末,回流脱色0、0.5、1、2、3小时,过滤,冷却后观察脱色液颜色并测定穿心莲内酯含量,计算穿心莲内酯减失量。结果见表14。Take 4 parts of Andrographis paniculata extract in 3.3.2, each 500ml (equivalent to 30g of crude drug), add 2.5g of activated carbon powder, reflux for decolorization for 0, 0.5, 1, 2, 3 hours, filter, observe the color of the decolorization solution after cooling and Determination of andrographolide content, calculation of andrographolide loss. The results are shown in Table 14.
表14活性炭加入量考察(n=3)Table 14 Investigation of the amount of activated carbon added (n=3)
“++”颜色最深;“+”颜色较浅"++" is the darkest color; "+" is lighter
由表14可见,随回流时间延长穿心莲内酯有少量降低,温度过高会破坏穿心莲内酯,若脱色时间太短,则未能达到脱色目的,故回流脱色时间选择1小时即可。As can be seen from Table 14, there is a small decrease in andrographolide as the reflux time prolongs, and if the temperature is too high, the andrographolide will be destroyed. If the decolorization time is too short, the decolorization purpose cannot be achieved, so the reflux decolorization time can be selected for 1 hour.
3.3.4浓缩体积考察3.3.4 Concentration volume inspection
取穿心莲药材粉末500g,按上述操作后得穿心莲脱色液,取穿心莲脱色5份,每份500ml(相当于生药31g),减压浓缩至1ml/g、2ml/g、3ml/g、5ml/g、8ml/g、10ml/g,静置过夜后测定滤液中穿心莲内酯含量。结果见图11。Get Andrographis paniculata medicinal material powder 500g, get Andrographis paniculata decolorization liquid after the above-mentioned operation, get Andrographis paniculata decolorization 5 parts, every part of 500ml (equivalent to 31g of crude drug), concentrate under reduced pressure to 1ml/g, 2ml/g, 3ml/g, 5ml/g , 8ml/g, 10ml/g, measure the andrographolide content in the filtrate after standing overnight. The results are shown in Figure 11.
由图11可见当浓缩至1ml/g时穿心莲内酯有大量析出,及穿心莲脱色液浓缩至1ml/g时即可。As can be seen from Figure 11, when concentrated to 1ml/g, andrographolide has a large amount of precipitation, and when the Andrographis paniculata decolorization solution is concentrated to 1ml/g, it gets final product.
3.3.5醇洗涤沉淀考察3.3.5 Investigation of Alcohol Washing and Precipitation
在前期预示试验中发现,3.3.4中沉淀为深黄色,经后续纯化、结晶操作得到穿心莲内酯结晶为黄色片状或针状结晶,且纯度仅能达到87%。通过预示发现使用少量乙醇洗涤沉淀后,沉淀颜色变为类白色,且通过纯化结晶后,结晶为物色片状或针状,纯度达95%以上,达到《中国药典》2010年版1部穿心莲内酯项下纯度的相关规定。In the previous prediction test, it was found that the precipitate in 3.3.4 was dark yellow, and the crystals of andrographolide obtained through subsequent purification and crystallization operations were yellow flake or needle crystals, and the purity could only reach 87%. According to the prediction, it is found that after washing the precipitate with a small amount of ethanol, the color of the precipitate becomes off-white, and after purification and crystallization, the crystallization is in the shape of flakes or needles, with a purity of more than 95%, which reaches Part 1 of andrographolide in the "Chinese Pharmacopoeia" 2010 edition. Relevant regulations on purity under this item.
故考察了乙醇洗涤沉淀时乙醇浓度、乙醇用量对洗涤效果的影响。具体试验方法及结果如下。Therefore, the effects of ethanol concentration and ethanol dosage on the washing effect were investigated. The specific test methods and results are as follows.
3.3.5.1乙醇用量3.3.5.1 Ethanol consumption
取3.3.4中沉淀4份,每份1g,分别置布氏漏斗中,加入0、3、5、8ml(0、3、5、8倍)95%乙醇洗涤,50℃减压干燥后观察沉淀颜色,并测定穿心莲内酯含量,计算穿心莲内酯减失量,结果见表15。Take 4 parts of the precipitate in 3.3.4, each 1g, put them in the Buchner funnel respectively, add 0, 3, 5, 8ml (0, 3, 5, 8 times) 95% ethanol to wash, dry under reduced pressure at 50°C and observe Precipitate color, and measure andrographolide content, calculate andrographolide loss amount, the results are shown in Table 15.
表15乙醇用量考察Table 15 Investigation of Ethanol Consumption
注:“+”表示沉淀颜色为黄色,“-”表示沉淀颜色为类白色Note: "+" indicates that the precipitate color is yellow, "-" indicates that the precipitate color is off-white
由表15可知,当乙醇加入量小于沉淀量5倍时,沉淀颜色为黄色,当乙醇加入量大于5倍时,沉淀颜色为类白色,故选择使用5倍量乙醇洗涤即可。It can be seen from Table 15 that when the amount of ethanol added is less than 5 times the amount of precipitation, the color of the precipitate is yellow, and when the amount of ethanol added is greater than 5 times, the color of the precipitate is off-white, so choose to use 5 times the amount of ethanol for washing.
3.3.5.2乙醇浓度考察3.3.5.2 Investigation of ethanol concentration
取3.3.4中沉淀4份,每份1g,分别置布氏漏斗中,加5ml65%、80%、95%乙醇洗涤,另一份不加乙醇洗涤,50℃减压干燥后观察沉淀颜色,并测定穿心莲内酯含量,计算穿心莲内酯减失量,结果见表16。Take 4 parts of the precipitate in 3.3.4, each 1g, put them in the Buchner funnel respectively, add 5ml of 65%, 80%, and 95% ethanol to wash, and wash the other part without ethanol, and observe the color of the precipitate after drying under reduced pressure at 50°C. And measure andrographolide content, calculate andrographolide loss amount, the results are shown in Table 16.
表16乙醇浓度考察Table 16 Investigation of ethanol concentration
注:“+”表示沉淀颜色为黄色,“-”表示沉淀颜色为类白色Note: "+" indicates that the precipitate color is yellow, "-" indicates that the precipitate color is off-white
由表16可知,当乙醇浓度小于80%时,虽然穿心莲内酯损失量较少,但沉淀颜色为黄色,当乙醇浓度大于80%时,沉淀颜色为类白色,故选择使用80%乙醇洗涤即可。As can be seen from Table 16, when the ethanol concentration is less than 80%, although the loss of andrographolide is less, the precipitate color is yellow. When the ethanol concentration is greater than 80%, the precipitate color is off-white, so it is selected to use 80% ethanol for washing. Can.
在后续的验证试验中发现,使用5倍量80%乙醇洗涤沉淀时,穿心莲内酯的损失量较大,可达到20%以上。因此,使用乙醇洗涤时,洗至沉淀颜色为类白色即可,再加少量水洗涤,洗至水溶液无色即可。In the follow-up verification test, it was found that when the precipitate was washed with 5 times the amount of 80% ethanol, the loss of andrographolide was relatively large, which could reach more than 20%. Therefore, when washing with ethanol, wash until the color of the precipitate is off-white, then add a small amount of water to wash until the aqueous solution is colorless.
3.3.6三氯甲烷纯化考察3.3.6 Purification investigation of chloroform
参考文献[9-10],利用脱水穿心莲内酯易溶于三氯甲烷,而穿心莲内酯不溶于三氯甲烷的性质,采用三氯甲烷静置的方式除去上述沉淀中脱水穿心莲内酯。考虑到三氯甲烷用量、静置时间及静置次数对除杂效果的影响,设计如下3个单因素试验,选择最佳试验方案。具体试验方法及结果如下。References [9-10] , using the property that dehydroandrographolide is easily soluble in chloroform, but andrographolide is insoluble in chloroform, the dehydroandrographolide in the above precipitate was removed by standing in chloroform. Considering the influence of the amount of chloroform, standing time and standing times on the impurity removal effect, the following three single factor experiments were designed to select the best test plan. The specific test methods and results are as follows.
3.3.6.1三氯甲烷用量考察3.3.6.1 Investigation on the amount of chloroform
取穿心莲药材粉末200g,按上述操作后得穿心莲内酯粗晶,干燥后取穿心莲内酯粗晶6份,每份1g,分别加入5、10、20、30、40、50ml三氯甲烷(相当于沉淀量5、10、20、30、40、50倍)静置1小时,过滤,干燥得精制穿心莲内酯粉末,分别测定其脱水穿心莲内酯含量,并计算脱水穿心莲内酯减失量。结果见表17。Get 200g of Andrographis paniculata medicinal material powder, obtain andrographolide coarse crystal after the above-mentioned operation, get 6 parts of andrographolide coarse crystal after drying, every part of 1g, add 5, 10, 20, 30, 40, 50ml trichloromethane (equivalent to Let stand for 1 hour at 5, 10, 20, 30, 40, 50 times the amount of sedimentation), filter, and dry to obtain refined andrographolide powder, respectively measure the dehydroandrographolide content, and calculate the loss of dehydroandrographolide. The results are shown in Table 17.
表17三氯甲烷用量考察Table 17 Chloroform dosage investigation
由表17可见,当三氯甲烷使用量大于沉淀量10倍时,脱水穿心莲内酯含量无显著降低,考虑到三氯甲烷残留及成本,选择10倍量三氯甲烷静置即可。It can be seen from Table 17 that when the amount of chloroform used is 10 times greater than the amount of precipitation, the content of dehydroandrographolide does not decrease significantly. Considering the residual chloroform and the cost, it is sufficient to select 10 times the amount of chloroform and let it stand.
3.3.6.1三氯甲烷静置时间考察3.3.6.1 Investigation on the standing time of chloroform
取穿心莲药材粉末200g,按上述操作后得穿心莲内酯沉淀,干燥后取穿心莲内酯沉淀4份,每份1g,加入10ml三氯甲烷,分别静置0.5、1、2、3小时,过滤,干燥得精制穿心莲内酯粉末,分别测定其脱水穿心莲内酯含量,并计算脱水穿心莲内酯减失量。结果见表18。Take 200g of Andrographis paniculata medicinal material powder, obtain andrographolide precipitation after the above operation, take 4 parts of andrographolide precipitation after drying, each part of 1g, add 10ml of chloroform, let stand for 0.5, 1, 2, 3 hours respectively, filter, Dry to obtain refined andrographolide powder, measure the content of dehydroandrographolide respectively, and calculate the loss of dehydroandrographolide. The results are shown in Table 18.
表18三氯甲烷用量考察Table 18 Chloroform dosage investigation
由表18可见,静置0.5小时,脱水穿心莲内酯减失量比例较小,静置1、2、3小时脱水穿心莲内酯减失量比例无明显变化,故选择静置1小时静置即可。It can be seen from Table 18 that the loss ratio of dehydroandrographolide is relatively small after standing for 0.5 hours, and there is no significant change in the loss ratio of dehydroandrographolide after standing for 1, 2, and 3 hours. Can.
3.3.6.1三氯甲烷静置次数考察3.3.6.1 Investigation on the standing times of chloroform
取穿心莲药材粉末200g,按上述操作后得穿心莲内酯沉淀,干燥后取穿心莲内酯沉淀3份,每份1g,加入10ml三氯甲烷,分别静置1、2、3次,每次1小时,过滤,干燥得精制穿心莲内酯粉末,分别测定其脱水穿心莲内酯含量。结果见表19。Take 200g of Andrographis paniculata medicinal material powder, and obtain andrographolide precipitation after the above operation, after drying, take 3 parts of andrographolide precipitation, each 1g, add 10ml of chloroform, let stand 1, 2, 3 times respectively, 1 hour each time , filtered, and dried to obtain refined andrographolide powder, and the content of dehydroandrographolide was determined respectively. The results are shown in Table 19.
表19三氯甲烷用量考察Table 19 Chloroform dosage investigation
由表19可见,静置次数对精制效果影响较大,静置3次后即可达到除去大量脱水穿心莲内酯的目的,选择静置3次即可。It can be seen from Table 19 that the number of times of standing has a great influence on the refining effect, and the purpose of removing a large amount of dehydroandrographolide can be achieved after standing for 3 times, and it is sufficient to choose to stand for 3 times.
3.4结晶3.4 Crystallization
参考文献[9-10],穿心莲内酯粗晶重结晶的方式主要为采用乙醇加热溶解,回收溶剂,静置析晶的方式纯化穿心莲内酯。References [9-10] , the method of recrystallization of coarse crystals of andrographolide is mainly to purify andrographolide by heating and dissolving with ethanol, recovering the solvent, and standing for crystallization.
取精制穿心莲内酯粉末4g,加入200ml95%加热使溶解,过滤,减压回收溶剂至半量,4℃静置过夜,过滤,得穿心莲内酯结晶。母液再次浓缩至半量,重复上述操作,得穿心莲内酯结晶,合并两次穿心莲内酯结晶,50℃减压干燥,得穿心莲内酯结晶。结果见表20。Take 4g of refined andrographolide powder, add 200ml of 95% and heat to dissolve, filter, recover the solvent to half the amount under reduced pressure, stand overnight at 4°C, filter to obtain andrographolide crystals. Concentrate the mother liquor to half the amount again, repeat the above operation to obtain andrographolide crystals, combine the two andrographolide crystals, dry under reduced pressure at 50°C, and obtain andrographolide crystals. The results are shown in Table 20.
表20结晶结果Table 20 Crystallization Results
由表20可见,根据上述结晶方法,经两次浓缩结晶制得穿心莲内酯结晶纯度均大于95%,符合《中国药典》要求。It can be seen from Table 20 that according to the above crystallization method, the crystal purity of andrographolide obtained through twice concentrated crystallization is greater than 95%, which meets the requirements of the "Chinese Pharmacopoeia".
3.5工艺验证3.5 Process verification
取穿心莲药材粗粉200g,按工艺流程操作,结果见表21。Take Andrographis paniculata crude powder 200g, operate according to the technological process, the results are shown in Table 21.
表21工艺验证Table 21 Process Validation
结果显示穿心莲内酯平均得率1.09,平均纯度为97.88%,得率及纯度RSD均小于5%,表明方法稳定可行。The results showed that the average yield of andrographolide was 1.09, the average purity was 97.88%, and the RSD of yield and purity were both less than 5%, indicating that the method was stable and feasible.
3.6小结3.6 Summary
最终确定穿心莲内酯提取、纯化工艺为:取穿心莲粗粉200g,加入1.5倍量95%乙醇,浸润30分钟,再加入4倍量95%乙醇,加热回流提取3次,每次2小时,过滤,合并3次滤液。滤液加蒸馏水调节乙醇浓度至65%,室温静置36h,过滤,滤液加0.5%活性炭粉末,加热回流脱色1小时,过滤,滤液减压回收乙醇至1g/ml(药材量/浓缩液体积),4℃静置36小时,过滤,得穿心莲内酯沉淀。穿心莲内酯沉淀加少量80%乙醇洗涤(洗涤沉淀至类白色),再加少量水洗涤(洗涤至水溶液无色),得穿心莲内酯白色粉末,穿心莲内酯白色粉末加10倍量三氯甲烷静置3次,每次1小时,过滤,得精制穿心莲内酯粉末。加入生药量1倍量95%乙醇,稍加热使精制穿心莲内酯粉末溶解,过滤,减压回收乙醇至半量,4℃静置过夜,使析晶,过滤,得穿心莲内酯结晶。母液再次减压回收溶剂至半量,过滤,合并两次穿心莲内酯结晶,50℃减压干燥2小时,即得。Final determination of andrographolide extraction, purification process is: get Andrographis paniculata coarse powder 200g, add 1.5 times the amount of 95% ethanol, infiltrate for 30 minutes, then add 4 times the amount of 95% ethanol, heat and reflux extraction 3 times, each time for 2 hours, filter , combined 3 filtrates. Add distilled water to the filtrate to adjust the ethanol concentration to 65%, let it stand at room temperature for 36 hours, filter, add 0.5% activated carbon powder to the filtrate, heat and reflux for 1 hour to decolorize, filter, and recover ethanol from the filtrate to 1g/ml (medicinal material amount/concentrate volume) under reduced pressure. Stand at 4°C for 36 hours, filter to obtain andrographolide precipitate. The andrographolide precipitate is washed with a small amount of 80% ethanol (washed and precipitated to off-white), and then washed with a small amount of water (washed until the aqueous solution is colorless), and the white powder of andrographolide is obtained, and the white powder of andrographolide is added with 10 times the amount of chloroform Let it stand for 3 times, each time for 1 hour, filter to obtain refined andrographolide powder. Add 1 times the amount of crude drug 95% ethanol, heat slightly to dissolve the refined andrographolide powder, filter, recover the ethanol to half the amount under reduced pressure, stand overnight at 4°C to crystallize, filter to obtain andrographolide crystals. The mother liquor was recovered under reduced pressure to reduce the solvent to half, filtered, combined two crystals of andrographolide, dried under reduced pressure at 50°C for 2 hours, and obtained.
3.7工艺流程3.7 Process flow
3.7.1关键工艺参数说明3.7.1 Description of key process parameters
说明:各步骤操作中溶液颜色、溶液体积、溶液密度等均为带溶液冷却后观察或测得。Note: The color of the solution, the volume of the solution, and the density of the solution in each step are all observed or measured after the solution is cooled.
[1]回流提取后,过滤后滤液呈绿色,体积约为2300~2600ml,密度约为0.790~0.810g/ml。[1] After reflux extraction, the filtered filtrate is green, with a volume of about 2300-2600ml and a density of about 0.790-0.810g/ml.
[2]加水静置,过滤后,滤液应呈黄绿色,体积约为3300~3700ml,密度约为0.890~0.910g/ml。[2] Add water and let it stand. After filtering, the filtrate should be yellow-green, with a volume of about 3300-3700ml and a density of about 0.890-0.910g/ml.
[3]加入0.5%活性炭回流脱色,过滤后,滤液呈黄色,体积约为2900~3300ml,密度约为0.890~0.910g/ml。[3] Add 0.5% activated carbon to reflux for decolorization. After filtration, the filtrate is yellow, with a volume of about 2900-3300ml and a density of about 0.890-0.910g/ml.
[4]脱色液减压浓缩时,为避免穿心莲内酯损耗,温度不宜过高,本研究选择为55℃。[4] When the decolorization solution is concentrated under reduced pressure, in order to avoid the loss of andrographolide, the temperature should not be too high. This study chooses 55°C.
[5]脱色液浓缩后,溶液呈黄色,溶液底部有大量黄色沉淀析出,体积约为200~300ml,密度约为1.05~1.25g/ml。4℃静置36小时后,底部有大量类白色沉淀析出。[5] After the decolorization solution is concentrated, the solution is yellow, and a large amount of yellow precipitates are precipitated at the bottom of the solution, with a volume of about 200-300ml and a density of about 1.05-1.25g/ml. After standing at 4°C for 36 hours, a large amount of off-white precipitate precipitated at the bottom.
[6]4℃第二次静置后,沉淀量较少,故舍去第二次静置析出沉淀步骤。[6] After standing still at 4°C for the second time, the amount of precipitation is less, so the second standing precipitation precipitation step is omitted.
[7]加入少量80%乙醇洗涤沉淀将沉淀洗至类白色即可,然后加少量水洗涤。[7] Add a small amount of 80% ethanol to wash the precipitate and wash the precipitate until off-white, then add a small amount of water to wash.
[8]结晶后减压回收乙醇时,为避免穿心莲内酯损耗,温度不宜过高,本研究选择为50℃。[8] When recovering ethanol under reduced pressure after crystallization, in order to avoid the loss of andrographolide, the temperature should not be too high, 50°C was selected in this study.
[9]结晶干燥时,为避免温度过高,并快速达到干燥目的,本研究选择减压干燥的方式,与50℃田间下干燥2小时。[9] During crystallization drying, in order to avoid excessive temperature and quickly achieve the purpose of drying, this study chooses the method of decompression drying and drying in the field at 50°C for 2 hours.
4穿心莲内酯质量检查4 Andrographolide Quality Check
4.1其他内酯4.1 Other lactones
取本品,加无水乙醇制成每1ml含2mg的溶液作为供试品溶液。照薄层色谱法(附录VIB)试验,吸取上述溶液10μl,点于硅胶G薄层板上,以三氯甲烷-甲醇(19:1)为展开剂,展开,取出,晾干,喷以2%3,5-二硝基苯甲酸的乙醇溶液与5%氢氧化钾的乙醇溶液的等量混合液(临用配制)。供试品色谱中,除主斑点外,不得显其他斑点(如图12)。Take this product, add absolute ethanol to make a solution containing 2mg per 1ml as the test solution. According to the thin-layer chromatography (Appendix VIB) test, draw 10 μl of the above solution, spot it on the silica gel G thin-layer plate, use chloroform-methanol (19:1) as the developer, develop, take it out, dry it, and spray it with 2 % 3,5-dinitrobenzoic acid ethanol solution and 5% potassium hydroxide ethanol solution in equal volume (preparation). In the chromatogram of the test product, except for the main spot, other spots shall not appear (as shown in Figure 12).
4.2干燥失重4.2 Loss on drying
取本品,在105℃干燥至恒重,减失重量不得过1.0%(附录ⅨG)。结果见表22。Take this product and dry it to constant weight at 105°C, and the weight loss should not exceed 1.0% (Appendix IXG). The results are shown in Table 22.
表22穿心莲内酯干燥失重(n=3)Table 22 andrographolide loss on drying (n=3)
由表22可见,3组结晶减失重量均小于1.0%,符合药典规定。It can be seen from Table 22 that the weight loss of the three groups of crystals is less than 1.0%, which meets the requirements of the Pharmacopoeia.
4.2含量测定4.2 Content determination
4.2.1色谱条件与系统适用性试验以十八烷基硅烷键合硅胶为填充剂;以甲醇-水(60:40)为流动相;检测波长为225nm。理论板数按穿心莲内酯峰计算应不低于5000。4.2.1 Chromatographic conditions and system suitability test Octadecylsilane bonded silica gel was used as filler; methanol-water (60:40) was used as mobile phase; detection wavelength was 225nm. The number of theoretical plates should not be less than 5000 based on the peak of andrographolide.
4.2.2对照品溶液的制备取穿心莲内酯对照品适量,精密称定,加甲醇制成每1ml含0.101mg的溶液,即得。4.2.2 Preparation of reference substance solution Take an appropriate amount of andrographolide reference substance, weigh it accurately, add methanol to make a solution containing 0.101mg per 1ml, and obtain it.
4.2.3供试品溶液的制备取本品约4.91、4.94、5.07mg,精密称定,置50ml量瓶中,加甲醇溶解并稀释至刻度,摇匀,即得。4.2.3 Preparation of the test solution Take about 4.91, 4.94, and 5.07 mg of this product, weigh them accurately, put them in a 50ml measuring bottle, add methanol to dissolve and dilute to the mark, shake well, and you get it.
4.2.4样品测定分别精密吸取对照品溶液与供试品溶液各10μl,注入液相色谱仪,测定,即得,结果见图13~14。4.2.4 Determination of samples Accurately draw 10 μl each of the reference substance solution and the test solution, inject it into the liquid chromatograph, and measure it. The results are shown in Figures 13-14.
本发明制备穿心莲内酯的方法,使用该方法具有如下特点:采用适宜工业大规模生产的回流法提取穿心莲内酯,提取效率高、耗时短、有机溶剂用量少、成本低;本发明采用醇提水沉、活性炭回流脱色相结合的方式除去叶绿素等杂质,具有活性炭使用量较少、解热时间短等优势,避免穿心莲内酯被活性炭吸附、长时间加热穿心莲内酯被分解;本研究采用乙醇洗涤穿心莲内酯粗晶除杂的方式,避免传统工艺中多次使用活性炭回流脱色除杂对穿心莲内酯的分解。制备过程中不使用大孔树脂;反应时间短,节约能源;产品安全有效,便于“三废”处理,利于环境保护;产品纯度高,穿心莲内酯含量可达97%以上;工艺过程操作简单,适合工业化生产。The method for preparing andrographolide of the present invention has the following characteristics: the reflux method suitable for industrial large-scale production is used to extract andrographolide, the extraction efficiency is high, the time consumption is short, the organic solvent consumption is small, and the cost is low; the present invention uses The combination of alcohol extraction, water sedimentation and activated carbon reflux decolorization removes impurities such as chlorophyll, which has the advantages of less activated carbon consumption and short antipyretic time, avoiding the adsorption of andrographolide by activated carbon and the decomposition of andrographolide by prolonged heating; this study The method of washing the coarse crystals of andrographolide with ethanol to remove impurities avoids the decomposition of andrographolide by repeated use of activated carbon to decolorize and remove impurities in the traditional process. No macroporous resin is used in the preparation process; the reaction time is short, saving energy; the product is safe and effective, convenient for "three wastes" treatment, and beneficial to environmental protection; the product has high purity, and the andrographolide content can reach more than 97%; the process is simple to operate, suitable for Industrial production.
参考文献:references:
[1]鹿萍、丁琤,盛敏丽.穿心莲内酯的超声波提取法研究.赤峰学院学报,2008,24(2):28-29[1] Lu Ping, Ding Teng, Sheng Minli. Study on Ultrasonic Extraction of Andrographolide. Journal of Chifeng University, 2008, 24(2): 28-29
[2]王红燕,刘雪飞.穿心莲内酯提取工艺.中医中药,2011,24(3):170[2] Wang Hongyan, Liu Xuefei. Extraction process of andrographolide. Traditional Chinese Medicine, 2011, 24(3): 170
[3]吴爱群,张国强.穿心莲内酯提取工艺研究.河池学院学报,2009,(5):66-68[3] Wu Aiqun, Zhang Guoqiang. Research on extraction process of andrographolide. Journal of Hechi University, 2009, (5): 66-68
[4]戴平,韦汉燕,黄桂香,等.穿心莲内酯提取工艺研究.科技信息,2010,(1):305-307[4] Dai Ping, Wei Hanyan, Huang Guixiang, etc. Research on the extraction process of andrographolide. Science and Technology Information, 2010, (1): 305-307
[5]张建强,张玲,王欢,等.穿心莲提取工艺研究.食品与药品,2005,7,(1):37-40[5] Zhang Jianqiang, Zhang Ling, Wang Huan, etc. Research on the extraction process of Andrographis paniculata. Food and Drugs, 2005, 7, (1): 37-40
[6]刘蕾,许笑笑,韩光.均匀设计法优化穿心莲内酯的提取工艺,河南大学学报,2006,25(4):33-35[6] Liu Lei, Xu Xiaoxiao, Han Guang. Optimizing the Extraction Process of Andrographolide by Uniform Design Method, Journal of Henan University, 2006, 25(4): 33-35
[7]马芝玉,林翠梧,廖森,等.微波和超声波辅助提取穿心莲内酯,精细化工,2007,24(8):758-760[7] Ma Zhiyu, Lin Cuiwu, Liao Sen, etc. Microwave and Ultrasonic Assisted Extraction of Andrographolide, Fine Chemical Industry, 2007, 24(8): 758-760
[8]杨涛,盛欢欢,李岩,等.星点设计-效应面法优化穿心莲提取工艺,中国药学杂志,2011,46(3):208-213[8] Yang Tao, Sheng Huanhuan, Li Yan, et al. Optimizing the Extraction Process of Andrographis paniculata by Star Point Design-Response Surface Method, Chinese Journal of Pharmaceutical Sciences, 2011, 46(3): 208-213
[9]卓菊,汪小根.正交设计研究穿心莲中脱水穿心莲内酯提取工艺.中南药学,2005,3(3):155-157[9] Zhuo Ju, Wang Xiaogen. Orthogonal design study on the extraction process of dehydroandrographolide from Andrographis paniculata. Zhongnan Pharmacy, 2005, 3(3): 155-157
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510640417.9A CN105153082A (en) | 2015-09-30 | 2015-09-30 | Large-scale production technology of andrographalide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510640417.9A CN105153082A (en) | 2015-09-30 | 2015-09-30 | Large-scale production technology of andrographalide |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105153082A true CN105153082A (en) | 2015-12-16 |
Family
ID=54794176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510640417.9A Pending CN105153082A (en) | 2015-09-30 | 2015-09-30 | Large-scale production technology of andrographalide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105153082A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111747912A (en) * | 2020-06-22 | 2020-10-09 | 河南中医药大学 | A kind of preparation method of diterpenoids |
CN118221617A (en) * | 2024-05-21 | 2024-06-21 | 成都通德药业有限公司 | Method for removing other lactones in andrographolide |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009059158A1 (en) * | 2007-11-02 | 2009-05-07 | Hutchison Medipharma Enterprises Limited | Andrographis paniculata extract |
CN101559088A (en) * | 2009-05-21 | 2009-10-21 | 雷允上药业有限公司 | Production technique of andrographolide and neoandrographolide, dehydroanddrographolide, oxyandrographolide |
CN101671322A (en) * | 2009-09-30 | 2010-03-17 | 合肥工业大学 | Method for separating and purifying andrograholide |
CN102382083A (en) * | 2010-09-01 | 2012-03-21 | 天津天士力现代中药资源有限公司 | Preparation method of andrographolide |
CN103145660A (en) * | 2013-03-25 | 2013-06-12 | 成都天台山制药有限公司 | Andrographolide and preparation method thereof |
CN103275042A (en) * | 2013-04-23 | 2013-09-04 | 四川省裕通生物技术有限公司 | Extraction and purification method for andrographolide |
CN103435578A (en) * | 2013-09-17 | 2013-12-11 | 南京通泽农业科技有限公司 | Method for extracting andrographolide from andrographis paniculata |
CN104031011A (en) * | 2014-06-30 | 2014-09-10 | 施佩蓓 | Method for producing andrographolide |
-
2015
- 2015-09-30 CN CN201510640417.9A patent/CN105153082A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009059158A1 (en) * | 2007-11-02 | 2009-05-07 | Hutchison Medipharma Enterprises Limited | Andrographis paniculata extract |
CN101559088A (en) * | 2009-05-21 | 2009-10-21 | 雷允上药业有限公司 | Production technique of andrographolide and neoandrographolide, dehydroanddrographolide, oxyandrographolide |
CN101671322A (en) * | 2009-09-30 | 2010-03-17 | 合肥工业大学 | Method for separating and purifying andrograholide |
CN102382083A (en) * | 2010-09-01 | 2012-03-21 | 天津天士力现代中药资源有限公司 | Preparation method of andrographolide |
CN103145660A (en) * | 2013-03-25 | 2013-06-12 | 成都天台山制药有限公司 | Andrographolide and preparation method thereof |
CN103275042A (en) * | 2013-04-23 | 2013-09-04 | 四川省裕通生物技术有限公司 | Extraction and purification method for andrographolide |
CN103435578A (en) * | 2013-09-17 | 2013-12-11 | 南京通泽农业科技有限公司 | Method for extracting andrographolide from andrographis paniculata |
CN104031011A (en) * | 2014-06-30 | 2014-09-10 | 施佩蓓 | Method for producing andrographolide |
Non-Patent Citations (7)
Title |
---|
M. RAJANI ET AL: "A Rapid Method for Isolation of Andrographolide from Andrographis Paniculata Nees Kalmegh", 《PHARMACEUTICAL BIOLOGY》 * |
广州第五制药厂 等: "穿心莲内酯(Andrographolide)提取工艺试验小结", 《广州医药》 * |
张春滨 等: "穿心莲内酯工艺改进探讨", 《中医药信息》 * |
杨静: "穿心莲内酯的研究进展", 《中草药》 * |
聂凌云 等: "穿心莲提取工艺的研究及热稳定性考察", 《解放军药学学报》 * |
赵朝伟: "穿心莲内酯原料药及其栓剂的研究", 《中国优秀博硕士学位论文全文数据库 (硕士) 工程科技Ⅰ辑》 * |
郭洁芬 等: "穿心莲内酯醇提工艺研究", 《中国民族民间医药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111747912A (en) * | 2020-06-22 | 2020-10-09 | 河南中医药大学 | A kind of preparation method of diterpenoids |
CN118221617A (en) * | 2024-05-21 | 2024-06-21 | 成都通德药业有限公司 | Method for removing other lactones in andrographolide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103833803B (en) | The method of sweeting agent in ultrasonic extraction and resin purification Pasania cuspidata leaf | |
CN102924416B (en) | Method for separating and purifying monomeric compounds from ash bark | |
CN101856435B (en) | Preparation method and content determination method of Daphne giraldii Nitsche total coumarin extract | |
CN102058641A (en) | Angelica dahurica extract and quality detection method | |
EP2650301A1 (en) | Method for preparing albiflorin and paeoniflorin | |
CN102631414A (en) | SepHaniadelavayi Diels total alkaloid extraction and purification technology | |
CN103830306B (en) | A kind of preparation method of folium lonicerae effective extract | |
CN106432167B (en) | A kind of method that theaflavin is extracted from black tea | |
CN102614119B (en) | Method for sinomenine hydrochloride injection by using non-organic solvent | |
CN102603632B (en) | Method for preparing sinomenine hydrochloride by using non-organic solvent | |
CN102600113A (en) | Organic solvent-free preparation method of sinomenine hydrochloride cataplasm | |
CN108129545B (en) | A kind of method for preparing triptolide | |
CN105153082A (en) | Large-scale production technology of andrographalide | |
CN1757647A (en) | The preparation method of gentiopicroside | |
CN102659861B (en) | Purification method of rhubarb stilbene glucoside | |
CN102924545B (en) | A kind of enrichment of akebiasaponin D and purification process | |
CN103860819A (en) | Method for extracting total flavonoid from anaesthetic plantain lily | |
He et al. | Research progress on the separation of alkaloids from chinese medicines by column chromatography | |
CN104825586A (en) | Method of extracting flavones from waste liquid after extraction of rose essential oil | |
CN110066256B (en) | Purification method of 5-chloro-2-methyl-4-isothiazolin-3-one | |
CN102600071B (en) | Method for preparing sinomenine hydrochloride infusion solutions and freeze-dried powder injections | |
CN109490448B (en) | A kind of preparation method of digoxin standard substance | |
CN101747391B (en) | Method for separating and preparing chemical reference substance of Icariin | |
CN102078400B (en) | Preparation method of extract of total triterpene acid of loquat leaf | |
CN112763609A (en) | Research method for screening and extracting process of anti-asthma active ingredients of chamomile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151216 |